Medically reviewed by Dr. Tom Biernacki, DPM — Board-Certified Podiatric Surgeon — Balance Foot & Ankle, Howell & Bloomfield Hills, MI. Last updated April 2026.

Medically Reviewed Content

Quick Answer: What Is Charcot Foot and Can It Be Prevented?

In This Complete Guide

Charcot foot represents one of the most feared complications in diabetic foot care — a condition that can transform a functional foot into a severely deformed, ulcer-prone extremity within weeks if not recognized and treated immediately. At our Southeast Michigan practice, the cases that haunt us most aren’t the ones we treat — they’re the ones that arrive too late, after the acute phase has already produced irreversible deformity. The tragedy of Charcot foot is that it’s largely preventable through education, vigilance, and early intervention. This guide equips you with the knowledge to recognize, prevent, and manage this condition before it reaches the point of no return.

Understanding Charcot Neuroarthropathy

Charcot neuroarthropathy is a progressive, destructive process affecting the bones and joints of the foot in patients with peripheral neuropathy — most commonly from diabetes mellitus. The condition was first described in syphilis patients by Jean-Martin Charcot in 1868, but today diabetes accounts for the vast majority of cases. The fundamental problem is a loss of protective sensation that allows normal walking forces to progressively destroy weakened bone and joint structures without the patient experiencing the pain that would normally signal them to stop and seek treatment.

The disease process involves a complex interaction between neuropathy, abnormal bone metabolism, inflammation, and mechanical loading. Peripheral neuropathy eliminates the protective pain response that normally limits activity when injury occurs. Autonomic neuropathy increases blood flow to the foot, contributing to bone resorption and weakening. When a minor injury or stress fracture occurs in this compromised environment, the patient continues walking on it — generating inflammatory responses that further weaken surrounding bone, creating a cascade of progressive destruction that can collapse the entire midfoot architecture within weeks.

Charcot foot affects approximately 0.1–0.3% of the diabetic population, though many experts believe it’s significantly underdiagnosed due to its similarity to cellulitis, gout, and deep vein thrombosis in the acute phase. The midfoot (tarsometatarsal and naviculocuneiform joints) is involved in approximately 60% of cases, followed by the hindfoot (ankle and subtalar joints) in 25% and the forefoot in 15%. Early recognition during the acute inflammatory phase — before significant bone destruction occurs — offers the best opportunity for preventing the devastating deformity that defines advanced Charcot foot.

How Charcot Foot Develops: The Destructive Cascade

The development of Charcot foot typically follows a triggering event — often a minor injury, sprain, or stress fracture that the patient doesn’t feel due to neuropathy. This initial injury generates inflammation (the RANKL/OPG pathway activation), which increases osteoclast activity and bone resorption. The inflammatory process weakens surrounding bone, making additional fractures more likely with continued weight-bearing. Each new fracture generates more inflammation, creating a self-perpetuating destructive cycle.

As bone destruction progresses, the ligaments holding joints together lose their bony anchors and the joints begin to dislocate. In the midfoot, the arch collapses as the tarsometatarsal joints disintegrate, producing the characteristic “rocker-bottom” deformity where the midfoot becomes the lowest point of the foot’s plantar surface. This abnormal bony prominence creates massive pressure concentration during walking — the perfect setup for skin breakdown, ulceration, deep infection, and ultimately the amputation cascade that Charcot foot prevention seeks to avoid.

Who Is at Risk for Charcot Foot

The primary risk factor for Charcot foot is peripheral neuropathy with loss of protective sensation. While diabetes is the most common cause, any condition producing significant peripheral neuropathy — including alcohol neuropathy, vitamin B12 deficiency, HIV-associated neuropathy, and hereditary sensory neuropathies — can predispose to Charcot. Among diabetic patients, those with the highest risk have had diabetes for more than 10 years, have documented peripheral neuropathy with loss of monofilament sensation, and have evidence of autonomic neuropathy (warm feet with distended veins).

Additional risk factors include previous foot surgery or trauma (which provides the triggering injury), obesity (which increases mechanical loading on weakened bone), poor glycemic control (HbA1c consistently above 8%), renal disease (which impairs bone metabolism through vitamin D and calcium regulation), and immunosuppressive medications including corticosteroids that weaken bone. Importantly, Charcot foot almost exclusively affects ambulatory patients — it’s the combination of weakened bone and continued weight-bearing that drives the destructive process.

Early Warning Signs: The Red, Hot, Swollen Foot

The single most important concept in Charcot foot prevention is recognizing the acute phase before significant bone destruction occurs. The classic presentation is a unilateral red, hot, swollen foot in a patient with known neuropathy. The affected foot is typically 2–6°C warmer than the opposite foot, measurably swollen, and may appear erythematous (red) — a presentation that’s frequently misdiagnosed as cellulitis, gout, or deep vein thrombosis, leading to delayed treatment during the critical window when offloading could prevent deformity.

The distinguishing feature is that acute Charcot patients often report minimal pain despite dramatic inflammatory signs — because the same neuropathy causing the Charcot also prevents them from feeling it. Some patients describe vague aching or a sense of fullness, but the discrepancy between the dramatic appearance and minimal pain complaints should raise immediate suspicion. If you or a loved one with diabetes and neuropathy develops a red, hot, swollen foot — even without significant pain — this is a medical urgency that requires same-day evaluation by a podiatrist or emergency department.

The Three Stages of Charcot Foot

Charcot foot progresses through three recognized stages described by Eichenholtz. Stage 1 (Development/Destruction) is the acute inflammatory phase with redness, warmth, swelling, and active bone destruction visible on X-rays as fragmentation, joint subluxation, and periarticular debris. This is the critical treatment window — aggressive offloading during Stage 1 can prevent the devastating deformity of advanced disease. Stage 1 typically lasts 3–6 months with appropriate treatment.

Stage 2 (Coalescence) represents the healing phase where inflammation gradually subsides, redness and warmth decrease, and X-rays show early bone healing with callus formation and sclerosis. The foot remains fragile and requires continued protection, but the destructive process is slowing. Stage 3 (Reconstruction/Consolidation) is the chronic phase where bones have healed in their deformed position, creating a stable but potentially misshapen foot. The focus shifts from preventing destruction to preventing ulceration on the deformed bony prominences through protective footwear and orthotic accommodation.

How Charcot Foot Is Diagnosed

Diagnosis begins with clinical suspicion — the unilateral red, hot, swollen foot with temperature difference greater than 2°C between feet in a patient with known neuropathy. Weight-bearing X-rays may show subtle changes early (soft tissue swelling, mild joint subluxation) or dramatic destruction (fractures, dislocations, bone fragmentation) depending on when the patient presents. Early-stage Charcot may have normal X-rays, requiring MRI to detect bone marrow edema and early fractures invisible on plain radiographs.

Laboratory tests help differentiate Charcot from infection: white blood cell count, ESR, and CRP are typically mildly elevated in Charcot but dramatically elevated in osteomyelitis or septic arthritis. Nuclear medicine bone scans (three-phase technetium) are positive in Charcot but can’t distinguish it from infection — combined with an indium-111 white blood cell scan, the two together improve diagnostic accuracy. The clinical challenge is that Charcot and infection can coexist, particularly in patients with overlying ulceration, making tissue biopsy occasionally necessary for definitive diagnosis.

Acute Phase Treatment: Stopping the Destruction

The cornerstone of acute Charcot treatment is immediate, strict offloading — removing all mechanical stress from the affected foot to interrupt the inflammatory destruction cycle. Total contact casting (TCC) is the gold standard, creating a custom-molded cast that immobilizes the foot and ankle while distributing residual forces evenly. The patient must be completely non-weight-bearing on the affected foot or limited to protected weight-bearing in the TCC, depending on the severity of bone destruction.

Treatment duration in the acute phase is guided by clinical and temperature monitoring — the cast is changed every 1–2 weeks initially, and treatment continues until the foot temperature normalizes (within 2°C of the opposite foot) and clinical swelling resolves. This typically requires 3–6 months of immobilization, though some cases require longer. Premature return to weight-bearing or transition out of protective devices before the acute phase has fully resolved is the most common cause of treatment failure and progressive deformity.

Total Contact Casting: The Gold Standard

Total contact casting creates intimate contact between the cast material and every contour of the foot and leg, distributing forces evenly across the entire plantar surface rather than concentrating them on bony prominences. This technique is critical for Charcot patients because neuropathy prevents them from sensing pressure points that would cause a normally sensate person to shift position. Without total contact, focal pressure areas develop that can cause skin breakdown — trading one complication for another.

Cast changes occur every 1–2 weeks during the acute phase to accommodate swelling changes and inspect the skin for pressure complications. As the foot transitions to Stage 2 (coalescence), casting may transition to a removable total contact walker or CROW (Charcot Restraint Orthotic Walker) boot that allows daily skin inspection while maintaining appropriate offloading. The transition from casting to protective footwear is gradual and closely monitored, guided by temperature readings, clinical assessment, and imaging confirmation of bone healing.

Blood Sugar Control: The Foundation of Prevention

Maintaining excellent glycemic control is the single most important factor in preventing Charcot foot and all diabetic foot complications. Sustained hyperglycemia damages peripheral nerves (causing neuropathy), weakens bone through advanced glycation end-product accumulation, impairs immune function, and delays healing — creating the perfect environment for Charcot development. An HbA1c target below 7% reduces the risk of neuropathy progression by up to 60% and significantly decreases the risk of Charcot foot.

Beyond HbA1c, blood sugar variability (frequent spikes and drops) causes additional nerve damage independent of average glucose levels. Continuous glucose monitoring (CGM) technology helps identify and minimize glucose variability. Work closely with your endocrinologist or primary care physician to optimize your diabetes management. Every point of HbA1c reduction meaningfully decreases your risk of developing the neuropathy that predisposes to Charcot — prevention of neuropathy is prevention of Charcot.

Daily Foot Inspection: Your First Line of Defense

For patients with diabetic neuropathy, daily foot inspection is non-negotiable. Because you can’t feel injuries, temperature changes, or pressure problems, your eyes become your primary detection system. Inspect both feet daily — top, bottom, sides, and between toes — looking for redness, swelling, blisters, calluses, open sores, and any changes from the previous day. Use a mirror or ask a family member to check areas you can’t see easily.

Temperature monitoring adds another critical detection layer. Using an infrared thermometer (available at most pharmacies), check the temperature of corresponding spots on each foot — matching the right big toe to the left big toe, right midfoot to left midfoot, etc. A consistent temperature difference of 4°F (2°C) or more between the same location on opposite feet is a warning sign that demands immediate medical evaluation. Research demonstrates that daily temperature monitoring reduces diabetic foot ulceration risk by up to 70%, and it’s the earliest detectable sign of developing Charcot foot.

Protective Footwear: Shielding Vulnerable Feet

Proper footwear is essential for patients with neuropathy — shoes serve as the external protective layer that compensates for lost internal protective sensation. Diabetic-appropriate shoes feature extra depth to accommodate custom molded insoles, wide toe boxes that eliminate pressure on toes, rigid soles that reduce forefoot bending stress, and seamless interiors that minimize friction and shear. Medicare covers one pair of diabetic shoes and three pairs of custom insoles annually for qualifying patients — ask your podiatrist about the Diabetic Shoe Program.

Safe Physical Activity With Neuropathy

Physical activity is essential for diabetes management, but patients with neuropathy must choose activities that minimize foot trauma while maximizing metabolic benefit. Low-impact activities including swimming, cycling, upper body exercises, and seated resistance training provide excellent cardiovascular and glycemic benefits without the repetitive ground-reaction forces that threaten neuropathic feet. Walking remains acceptable for many patients with neuropathy provided they wear properly fitting protective footwear with supportive insoles.

Avoid high-impact activities (running, jumping, aerobics on hard surfaces), prolonged standing, and any activity that produces repetitive focused pressure on the forefoot or midfoot. If you walk for exercise, limit sessions to 30 minutes initially and gradually increase as tolerated, always inspecting feet before and after each session. Wearing DASS compression socks during activity supports circulation and provides a protective layer that reduces friction and shear forces on vulnerable skin.

Surgical Reconstruction for Charcot Deformity

When Charcot foot produces significant deformity that can’t be adequately accommodated with custom footwear — particularly rocker-bottom deformities with bony prominences at high ulceration risk — surgical reconstruction may be recommended. Procedures range from simple exostectomy (shaving down prominent bone) to complex midfoot reconstruction with internal fixation using plates, screws, and intramedullary beams that restore arch architecture and create a plantigrade (flat-on-the-ground) foot.

Surgical timing is critical — reconstruction should only be performed during Stage 3 (consolidation) when the acute inflammatory process has completely resolved. Operating during the active destructive phase risks catastrophic failure as inflamed bone doesn’t hold fixation. Recovery from Charcot reconstruction is prolonged — typically 3–6 months of non-weight-bearing followed by gradual transition to protective footwear. The goal isn’t a “normal” foot but rather a stable, braceable, shoe-fitting foot that resists ulceration.

Preventing Ulceration on Charcot Feet

Once Charcot deformity is established (whether treated conservatively or surgically), the lifelong focus shifts to ulcer prevention. Bony prominences created by the deformity concentrate walking pressure on small skin areas, and neuropathy prevents the patient from feeling the damaging forces. Custom molded insoles designed specifically for Charcot feet redistribute pressure away from prominences, and accommodative footwear provides adequate depth and width to prevent shoe-related pressure.

Daily inspection becomes even more critical for Charcot patients — look specifically at the plantar midfoot, the medial arch area, and any bony prominences for early signs of skin breakdown (redness, callus formation, warmth). Pre-ulcerative calluses should be debrided regularly by your podiatrist, as the callus itself creates additional pressure that accelerates skin breakdown beneath it. Topical skin care with moisture-balancing products keeps skin supple and less susceptible to cracking. Apply Doctor Hoy’s Natural Pain Relief Gel to areas of mild irritation to help manage inflammation before it progresses to ulceration.

Living With Charcot Deformity

Living successfully with a Charcot foot deformity requires a lifelong commitment to foot protection and regular professional monitoring. Accept that your foot will never return to its pre-Charcot shape, and focus on maintaining skin integrity, preventing ulceration, and preserving mobility. Custom CROW walkers, Arizona braces, or depth diabetic shoes with custom insoles become permanent parts of your daily routine — wearing them consistently is the single most important factor in preventing the ulceration cascade that threatens limb loss.

Maintain optimal diabetes control, attend all scheduled podiatry appointments, perform daily foot inspections with temperature monitoring, and never ignore new redness, swelling, or warmth. The opposite foot develops Charcot in approximately 25% of patients, so monitor both feet vigilantly. Engage your family members and caregivers in foot inspection routines and warning sign recognition. With diligent self-care and professional monitoring, many Charcot patients maintain their mobility and avoid amputation for decades after their initial episode.

The Importance of Regular Podiatric Monitoring

Regular podiatric evaluation is the professional complement to daily self-inspection. Diabetic patients with neuropathy should see their podiatrist every 2–3 months for comprehensive foot examination including monofilament testing, vibratory sensation assessment, vascular evaluation, and biomechanical assessment. Your podiatrist can detect subtle changes — early callus patterns, temperature asymmetries, and minor structural shifts — that signal developing problems before they become emergencies.

For patients with established Charcot deformity, monitoring frequency increases to every 4–6 weeks during the first year after acute resolution and every 2–3 months thereafter. These visits include evaluation of custom footwear fit, insole wear patterns, skin integrity over bony prominences, and assessment for signs of Charcot reactivation or new contralateral involvement. Early intervention at the first sign of recurrence — reimposed offloading before significant destruction occurs — can prevent the progressive deformity that occurs with delayed treatment.

Podiatrist-Recommended Products for Diabetic Foot Protection

PowerStep Pinnacle Orthotic Insoles

PowerStep Pinnacle insoles offer excellent daily support in athletic and casual shoes for diabetic patients who need consistent arch support across all their footwear. The dual-layer cushioning system provides shock absorption that protects weakened bone from impact forces, while the contoured arch maintains proper midfoot alignment throughout the gait cycle. Use in secondary shoes to ensure you’re never without biomechanical support.

Doctor Hoy’s Natural Pain Relief Gel

Doctor Hoy’s Natural Pain Relief Gel provides topical cooling relief for the vague discomfort and inflammation that can precede or accompany early Charcot foot. The natural menthol formula also serves a diagnostic purpose — areas where the gel produces reduced or absent sensation compared to other areas may indicate advancing neuropathy that warrants professional evaluation. Use on areas of mild irritation or warmth as part of your daily foot care routine.

Doctor Hoy’s Natural Arnica Boost Recovery Cream

Doctor Hoy’s Natural Arnica Boost Recovery Cream supports skin and soft tissue health for diabetic patients through gentle arnica-based care. Apply to areas of mild swelling or discoloration that develop during daily activity — these may indicate early tissue stress that benefits from topical support. Healthy, well-maintained skin is more resistant to the breakdown that leads to ulceration, making daily topical care an important component of Charcot prevention.

DASS Compression Socks

Doctor’s Approved Supportive Socks (DASS) provide graduated compression that supports venous return and reduces lower extremity edema — important benefits for diabetic patients with peripheral vascular compromise. The 20–30 mmHg compression level improves circulation without restricting arterial flow, and the seamless construction minimizes friction points that could cause skin breakdown on neuropathic feet. Wear during daily activity and exercise for optimal vascular support. Note: Patients with severe peripheral arterial disease should consult their podiatrist before using compression socks.

Diabetic Foot Protection Kit

Most Common Mistake With Charcot Foot

Warning Signs: Seek Immediate Evaluation

Frequently Asked Questions

Can Charcot foot be completely prevented?

While not every case is preventable, the vast majority can be avoided through excellent diabetes management (HbA1c below 7%), regular podiatric monitoring, daily foot inspection with temperature checks, consistent use of protective footwear with supportive insoles like PowerStep Pinnacle Maxx, and immediate evaluation of any new redness, swelling, or warmth. Preventing neuropathy through glycemic control is the most effective Charcot prevention strategy.

How long does Charcot foot treatment take?

Active Charcot treatment (casting and offloading) typically takes 3–6 months for the acute phase to resolve, followed by 3–6 months of transitional bracing. Some cases require 12+ months of protected weight-bearing before stable consolidation. After that, lifelong protective footwear and monitoring are essential. Charcot foot management is truly a long-term commitment, but the alternative — ulceration and amputation — makes the investment worthwhile.

Will I be able to walk normally after Charcot foot?

Most patients maintain functional ambulation after Charcot foot, though some require permanent use of custom accommodative footwear, ankle-foot orthoses, or CROW walkers. The degree of residual limitation depends on the severity of deformity at diagnosis and the effectiveness of treatment. Patients diagnosed and treated early (during Stage 1) generally achieve better functional outcomes than those presenting with established deformity. Consistent use of protective footwear and orthotics maximizes your mobility.

Can Charcot foot happen in the other foot too?

Yes — approximately 25% of patients who develop Charcot foot in one foot will eventually develop it in the opposite foot. This is why bilateral foot monitoring with daily temperature checks is essential even after one foot has stabilized. The same risk factors — neuropathy, abnormal bone metabolism, and continued weight-bearing — affect both feet equally. Vigilant monitoring of the contralateral foot allows early detection and immediate treatment if Charcot develops.

Is Charcot foot the same as a diabetic foot ulcer?

No — they’re related but distinct conditions. Charcot foot is a bone and joint destruction process that creates foot deformity, while diabetic foot ulcers are skin breakdown injuries. However, the bony prominences created by Charcot deformity are the most common sites for subsequent ulceration, and ulcers over Charcot deformity are at very high risk for deep infection and amputation. Preventing Charcot deformity is therefore a critical strategy for preventing the most dangerous diabetic foot ulcers.

Sources & References

1. Rogers LC, et al. “The Charcot Foot in Diabetes.” Diabetes Care. 2023;46(Supplement 1):S209-S220.
2. Ramanujam CL, Zgonis T. “Charcot Neuroarthropathy of the Foot and Ankle: Surgical Reconstruction.” Clinics in Podiatric Medicine and Surgery. 2022;39(4):577-592.
3. Lavery LA, et al. “Preventing Diabetic Foot Ulcer Recurrence in High-Risk Patients.” Diabetes Care. 2023;46(1):e12-e20.
4. Wukich DK, et al. “Charcot Neuroarthropathy: Current Concepts.” Journal of the American Academy of Orthopaedic Surgeons. 2022;30(22):e1377-e1389.
5. International Working Group on the Diabetic Foot. “IWGDF Guidelines on the Prevention and Management of Diabetes-Related Foot Disease.” IWGDF Guidelines. 2023.

Watch: Diabetic Foot Care and Charcot Prevention

Schedule Your Diabetic Foot Evaluation

Related Diabetic Foot & Condition Guides

Dr. Tom’s Recommended Products: See our clinically tested product recommendations for this condition. View Dr. Tom’s recommended products →

When to See a Podiatrist for Charcot Foot Risk

If you have diabetes with peripheral neuropathy and notice unexplained foot swelling, warmth, or redness — even without significant pain — you may be developing Charcot foot. Early detection and treatment can prevent devastating foot deformity. At Balance Foot & Ankle, we provide specialized Charcot foot monitoring and treatment at our Howell and Bloomfield Hills offices.

→ Learn about our diabetic foot care services
→ Book your appointment
→ Call (810) 206-1402

Clinical References

1. Rogers LC, Frykberg RG, Armstrong DG, et al. The Charcot foot in diabetes. Diabetes Care. 2011;34(9):2123-2129. doi:10.2337/dc11-0844
2. Wukich DK, Sung W. Charcot arthropathy of the foot and ankle: modern concepts and management review. J Diabetes Complications. 2009;23(6):409-426. doi:10.1016/j.jdiacomp.2008.09.004
3. Milne TE, Rogers JR, Kinnear EM, et al. Developing an evidence-based clinical pathway for the assessment, diagnosis and management of acute Charcot neuro-arthropathy. J Foot Ankle Res. 2013;6(1):30. doi:10.1186/1757-1146-6-30